Explore NextGen Omics & Spatial Biology US 2025: Advancing Therapeutic Innovation Through Multi-Omic Analysis – Celebrating its 11th Year. 

Join us at NextGen Omics & Spatial Biology US 2025, a premier event celebrating its 11th year of advancing therapeutic innovation through multi-omic analysis. This gathering brings together over 1,000 senior experts in multi-omics and spatial analysis from leading pharmaceutical, biotech, and life sciences companies, creating a vibrant platform for collaboration and innovation. 

Over the course of two action-packed days in March, participants will have the chance to accelerate the adoption of cutting-edge multi-omic and spatial techniques in drug discovery and clinical research. The event will feature a diverse array of presentations, panel discussions, and interactive workshops, offering deep dives into the latest advancements and practical applications. 

Attendees will engage in meaningful discussions about the industry’s most pressing challenges, ranging from data analysis and reproducibility to sample management and clinical design. These conversations will provide invaluable insights and foster collaborations that can drive the field forward. 

Whether you are looking to enhance your current projects, explore new directions, or simply stay abreast of the latest trends and technologies, NextGen Omics and Spatial Biology US 2025 is the place to be. 

Don’t miss out on this opportunity to be at the forefront of multi-omic and spatial biology innovation, contributing to the future of drug discovery and clinical research. Join us and be part of the conversation that shapes the next decade of therapeutic development. 

NGS, Clinical Omics & Diagnostics

Expand the applications of next-generation sequencing in your clinical & diagnostic workflows through Next Generation Sequencing & Clinical Diagnostics, highlighting the most need-to-know innovations in diagnostics, clinical genomics & bioinformatic technologies. Industry leading speakers will showcase effective strategies for integrating NGS techniques within drug development, with further discussion on standardizing bioinformatics, optimizing NGS-based assays and utilizing multi-omic data.

• Over 600 end users representing internationally renowned research & academic institutions, healthcare organisations and leading biopharma institutions
• Over 50 presentations focussed on the critical issues in NGS implementation and data integration
• Take a deep dive into data harmonisation, integration and analysis. Presentations will include tools for analysing high-throughput sequencing data, large-scale multi-omics data analysis and AI/ML toolkits for multi-omics datasets
• Discuss digital PCR & liquid biopsies. Hear from key opinion leaders’ in-depth presentations on PCR machines for NGS library preparation, developing nextgen MRD assays and advances in analysing cell-free DNA & CTCs  

Single Cell Analysis

Recent advances in single cell analytical tools have enabled increasingly deep cellular analyses at the genomic, transcriptomic and proteomic level. Join Single Cell Analysis to learn how to integrate the most exciting new techniques within drug development, from identifying novel therapeutic targets through to understanding patient responses to specific therapies. In-depth case studies also showcase emerging spatial approaches, with discussion on how to optimize their use within R&D.

• Over 450 end users representing internationally renowned research & academic institutions, healthcare organisations and leading biopharma institutions
• Over 40 presentations focussed on the most innovative spatial and single cell technologies, and their applications within diagnostics, clinical research and drug discovery
• Advance your understanding emerging single cell technologies from novel technologies for single cell imaging, through to one pot assays, benchmarking single cell technologies and updates from single cell multi-omics, applying omics in the clinic, bioinformatics for single cell analysis and clinical genomics updates

Spatial Multi-Omics

Unlocking the Potential of Spatial Technologies 

Spatial Multi Omics are transforming drug development, allowing researchers to more precisely understand biological systems than ever before. At Spatial US, experts from across leading academic institutions and biopharma organizations showcase the most transformative spatial tools and their applications in target identification, biomarker discovery, translational research & Clinical Design. From data analytics to successful therapeutic case studies, it equips you with the information you need to successfully adopt spatial technologies into your workflows. 

• Hear from and meet with the key innovators in spatial multi-omics. 2024 attendees included: Distinguished University Professor, George Mason University; Senior Scientist, AbbVie; Principal Scientist, Boehringer Ingelheim
• New to 2025! Gain invaluable insights into novel multi-omics technologies for spatial genomics & transcriptomics. Presentations will include translating spatial imaging techniques & approaches into drug development multi-modality processing and spatial transcriptomic databases
• New to 2025! Discuss spatial biology for oncology, immunology and neuroscience. Hear from expert speakers discussing the tumour environment, distribution of immune cells within the tumour and mapping cellular diversity in the brain  
• New to 2025! Advance your understanding on novel multi-omics technologies for spatial proteomics & metabolomics: from developing novel technologies for protein analysis through to automated multi-omics workflows, spatial distribution of proteins within cell and distribution of metabolites at spatial resolution
• Join a series of workshops, panel discussions & roundtables. Discussion sessions will include: ‘Overcoming the Challenges of Spatial Data Analysis’